Company intelligence / Profile preview

BOLDSCIENCE

Alpharetta, Georgia, United Statesboldsci.com ↗

Ownership: Private
Employees: ~120
Development stage: Preclinical

Overview

BOLDSCIENCE delivers scientifically creative medical communications and strategic support for pharmaceutical and biotech companies. It specializes in clinical trial recruitment materials, publication strategies, brand creation, regulatory approval support through its BOLDAPPROVALS division, and digital patient engagement solutions. The company has seen rapid growth as a trusted partner for global pharma and biotech clients[1][3][4].

It was acquired by Minds + Assembly in November 2024[3].

No clinical results or pipeline as it does not develop drugs.

Industry: Consulting

Partnerships

Works with major pharmaceutical and biotechnology companies globally; specific partners not disclosed publicly

Beyond the preview

Go deeper on BOLDSCIENCE.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BOLDSCIENCE.

Explore the full profile